FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfilePrenetics Global Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PRENW
Prenetics Global Limited Stock AnalysisComprehensive stock analysis for Prenetics Global Limited (PRENW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPRENW
PRENW
Prenetics Global Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PRENW
  1. Home
  2. Stocks
  3. Prenetics Global Limited

Prenetics Global Limited

🇺🇸PRENW•NASDAQ

Prenetics Global Limited

🇺🇸PRENW•NASDAQ
Market cap
$157.81M

Your view on PRENW

Mkt Cap
$157.81M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Prenetics Global Limited

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Sheng Wu Yeung
Headquarters
Unit 701-706, K11 Atelier King’s Road, Hong Kong, HK
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Sheng Wu Yeung
Headquarters
Unit 701-706, K11 Atelier King’s Road, Hong Kong, HK
Description

Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing.

Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology.

The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem.

Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Prenetics Global Limited. Starting points for Prenetics Global Limited: EPS -$4.90, beta 0.25 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Prenetics Global Limited. Trailing twelve-month EPS for Prenetics Global Limited stands at -$4.90. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Prenetics Global Limited. Prenetics Global Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold PRENW12 companies
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
TDSGFTelo Genomics Corp.HealthcareOTC$3.8M
TELO.VTelo Genomics Corp.HealthcareTSXV$4.0M
THOXFBioPorto A/SHealthcareOTC$73.8M
TMOThermo Fisher Scientific Inc.HealthcareNYSE$248.1B
TMO.NEThermo Fisher Scientific Inc.HealthcareNEO—
TOMDFTodos Medical Ltd.HealthcareOTC$14,081
TTOOT2 Biosystems, Inc.HealthcareOTC$11,218
TWSTTwist Bioscience CorporationHealthcareNASDAQ$7.0B
VCYTVeracyte, Inc.HealthcareNASDAQ$2.0B
VIMGFVimian Group AB (publ)HealthcareOTC$1.5B
VRCDFVerici Dx plcHealthcareOTC$4.5M
WATWaters CorporationHealthcareNYSE$43.3B
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Prenetics Global Limited, and how their positions are changing. At a $157.8M market value, institutional positions materially move Prenetics Global Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Prenetics Global Limited executives and directors. Shares of Prenetics Global Limited have traded between $0.01 and $0.02 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Prenetics Global Limited. Coverage tracks Prenetics Global Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Prenetics Global Limited.

PRENW AnalysisFair
Past
1
Growth
5
Health
3
Profit
1
Value
1